Improving Resection Rates Among African Americans With NSCLC

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

April 23, 2015

Primary Completion Date

August 23, 2019

Study Completion Date

September 9, 2019

Conditions
Non-small Cell Lung Cancer (NSCLC)
Interventions
OTHER

Usual Care

Usual care includes: complete staging work-up (CT/PET scan and possible mediastinoscopy), surgical consultation with a general or cardiothoracic surgeon, cardiac clearance and/or pulmonary function testing (if deemed necessary by the evaluating surgeon), surgical resection (wedge resection, lobectomy, pneumonectomy, or radiosurgery, as indicated by the size and location of the tumor), and adjuvant therapy (radiotherapy and/or chemotherapy, as determined by the intraoperative findings and pathology results).

OTHER

Intervention Arm

The proposed Intervention (EPDPN) will be administered by the PNs at the intervention sites on an outpatient basis. Several defining, fundamental characteristics of the PNs will ensure consistency of the intervention delivery across the various study sites.

Trial Locations (10)

19111

Fox Chase, Philadelphia

19958

Beebe Healthcare Tunnell Cancer Center, Lewes

23298

Virginia Commonwealth University, Richmond

27127

Wake Forest University Health Sciences, Winston-Salem

31405

Saint Joseph's/Candler Hospital, Savannah

48073

Beaumont Hospital - Royal Oak, Royal Oak

55426

Metro-Minnesota NCORP, Saint Louis Park

60612

Stroger Hospital of Cook County, Chicago

70121

Ochsner NCORP, New Orleans

89106

Nevada Cancer Research Foundation, Las Vegas

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT01885455 - Improving Resection Rates Among African Americans With NSCLC | Biotech Hunter | Biotech Hunter